×
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF
$ 40.00
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) PDF
$ 40.00
Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
×
Priapism Lasting 19 Hours With Combined Use of Trazodone and Mirtazapine in a Patient With History of Successfully Tolerating Each Agent as Monotherapy PDF
$ 40.00
Priapism Lasting 19 Hours With Combined Use of Trazodone and Mirtazapine in a Patient With History of Successfully Tolerating Each Agent as Monotherapy PDF quantity
$ 40.00
×
Joy Journal: A Behavioral Activation Technique Used in the Treatment of Late-Life Depression Associated With Hopelessness During the COVID-19 Pandemic PDF
$ 40.00
Joy Journal: A Behavioral Activation Technique Used in the Treatment of Late-Life Depression Associated With Hopelessness During the COVID-19 Pandemic PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
